These findings will be helpful for better understanding the clinical and biological significances of the CCL5/receptors axis in the breast cancer microenvironment, and the CCL5-CCR3 axis may be an important target to improve the prognosis of breast cancer patients. This evidence concerns the gene CCL5 and breast cancer.